All posts by: Michael Zand

About Michael Zand

Macrophages steal the show – Nature.com

Continue reading

2017-06-29 NEWS

Nature.com

Macrophages steal the show
Nature.com
The past decade has seen remarkable advances in tumour immunology due to extensive research on inhibition of programmed cell death protein 1 (PD1) — which is expressed on T cells — and its ligand PDL1, which is expressed on tumour cells. However …

Continue reading

2017-06-29 NEWS

Proactive Investors UK

ReNeuron Group upbeat as it progresses on all stem cell fronts
Proactive Investors UK
Stem cell therapy specialist Reneuron PLC (LON:RENE) is making good progress on all of its clinical trial candidates and also in the lab, chief executive Olav Hellebo said today. “Our therapeutic development programmes have continued to progress well …

and more »

Continue reading

2017-06-29 NEWS

Proactive Investors UK

ReNeuron Group upbeat as it progresses on all stem cell fronts
Proactive Investors UK
Stem cell therapy specialist Reneuron PLC (LON:RENE) is making good progress on all of its clinical trial candidates and also in the lab, chief executive Olav Hellebo said today. “Our therapeutic development programmes have continued to progress well …

and more »